Strategic Information, Evaluation and Research

View all:

Scaling up pediatric HIV care and treatment in Africa: clinical site characteristics associated with favorable service utilization

Journal Articles

By Adjorlolo-Johnson G1, Wahl Uheling A, Ramachandran S. et al. J Acquir Immune Defic Syndr. January 2013

To improve pediatric enrollment and retention in HIV treatment programs in Africa, this study examined factors associated with service utilization within EGPAF programs in Côte d'Ivoire, Mozambique, South Africa, Tanzania and Zambia.

Read more

A multi-disciplinary approach to implementation science: the NIH-PEPFAR PMTCT implementation science alliance

Journal Articles

By Sturke R, Harmston C, Simonds RJ, et al. J Acquir Immune Defic Syndr. November 2014.

In resource-limited countries, interventions to prevent mother-to-child HIV transmission have not yet realized their full potential health impact, illustrating the common gap between the scientific proof of an intervention's efficacy and effectiveness and its successful implementation at scale into routine health services.  

Read more

Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d’Ivoire

Journal Articles

By Auld AF, Ekra KA, Shiraishi RW, et al. PloSOne May 2014.

This study conducted a retrospective chart review to assess trends in patient characteristics and attrition (death or loss to follow-up) over time, among a nationally representative sample of 3,682 adults (≥15 years) initiating antiretroviral therapy during 2004-2007 at 34 health facilities.

Read more

Strategic Information and Evalution

Issue Briefs

EGPAF prides itself on its data management, accountability to donors and supported government, and use of high-quality data to scare up effective HIV prevention, care and treatment programs. This brief describes our data collection, management and evaluation procedures and innovations. 

Download

Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Cote d’Ivoire

Journal Articles

By Auld AF, Tuho MZ, Ekra KA, et al. Int J Tuberc Lung Dis. April 2014.

The objective of this study is to estimate tuberculosis incidence and determinants among ART enrollees.  

Read more

Using Data to Understand and Address Gaps in the Treatment Cascade for HIV-Positive Infants and Young Children: Experiences from Lesotho, Malawi, and Swaziland

Technical Briefs

This brief describes our ViiV-supported work in three countries to use monitoring and evaluation to assess and address gaps in HIV-positive children's access to antiretroviral treatment.

Download

Temporal Trends in Mortality and Loss to Follow-up Among Children Enrolled in Côte d’Ivoire’s National Antiretroviral Therapy Program

Journal Articles

By Auld AF, Tuho MZ, Ekra KA, et al. Pediatr Infect Dis J. November 2014.

During 2004-2008, >2000 children (<15 years old) initiated antiretroviral therapy (ART) in Côte d'Ivoire. Nationally representative outcomes, temporal trends in outcomes during 2004-2008 and site-level outcome determinants have not been investigated.

Read more

What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis

Journal Articles

By Ciaranello A, Perez F, Keatinge J, et al. PLoS Med. January 2012.

This study investigated uptake of prevention of mother-to-child HIV transmission services, infant feeding recommendations, and specific drug regimens necessary to achieve elimination of mother-to-child transmission of HIV in Zimbabwe.  

Read more

Pregnancy outcomes and birth defects from an antiretroviral drug safety registry for women in South Africa and Zambia

Journal Articles

By Liu KC, Farahani M, Mashamba T, et al. AIDS September 2014.

This study evaluates the safety of combination antiretroviral therapy in conception and pregnancy in different health systems.

Read more

 < 1 2 3 4 >